189 related articles for article (PubMed ID: 36243798)
1. A novel microRNA signature for the detection of melanoma by liquid biopsy.
Sabato C; Noviello TMR; Covre A; Coral S; Caruso FP; Besharat ZM; Splendiani E; Masuelli L; Battistelli C; Vacca A; Catanzaro G; Po A; Anichini A; Maio M; Ceccarelli M; Di Giacomo AM; Ferretti E
J Transl Med; 2022 Oct; 20(1):469. PubMed ID: 36243798
[TBL] [Abstract][Full Text] [Related]
2. Validation of a microRNA liquid biopsy assay for diagnosis and risk stratification of invasive cutaneous melanoma.
Van Laar R; Latif B; King S; Love C; Taubenheim N; Kalansooriya E; Wang W; Saad M; Winship I; Azzi A; Lilleyman A; Landgren T
Br J Dermatol; 2023 Aug; 189(3):292-301. PubMed ID: 37144735
[TBL] [Abstract][Full Text] [Related]
3. A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer.
Nakamura K; Hernández G; Sharma GG; Wada Y; Banwait JK; González N; Perea J; Balaguer F; Takamaru H; Saito Y; Toiyama Y; Kodera Y; Boland CR; Bujanda L; Quintero E; Goel A
Gastroenterology; 2022 Nov; 163(5):1242-1251.e2. PubMed ID: 35850198
[TBL] [Abstract][Full Text] [Related]
4. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
[TBL] [Abstract][Full Text] [Related]
5. Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer.
Lu S; Kong H; Hou Y; Ge D; Huang W; Ou J; Yang D; Zhang L; Wu G; Song Y; Zhang X; Zhai C; Wang Q; Zhu H; Wu Y; Bai C
Lung Cancer; 2018 Sep; 123():44-51. PubMed ID: 30089594
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Bao S; Hu T; Liu J; Su J; Sun J; Ming Y; Li J; Wu N; Chen H; Zhou M
J Nanobiotechnology; 2021 Jan; 19(1):22. PubMed ID: 33436002
[TBL] [Abstract][Full Text] [Related]
7. Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
Ricciardi E; Giordani E; Ziccheddu G; Falcone I; Giacomini P; Fanciulli M; Russillo M; Cerro M; Ciliberto G; Morrone A; Guerrisi A; Valenti F
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835424
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNA biomarkers in melanoma and non-melanoma skin cancer.
Durante G; Broseghini E; Comito F; Naddeo M; Milani M; Salamon I; Campione E; Dika E; Ferracin M
Expert Rev Mol Diagn; 2022 Mar; 22(3):305-318. PubMed ID: 35235479
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNA Signature Predicts Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.
Wada Y; Shimada M; Morine Y; Ikemoto T; Saito Y; Zhu Z; Wang X; Etxart A; Park Y; Bujanda L; Park IJ; Goel A
JCO Precis Oncol; 2021; 5():. PubMed ID: 34913022
[TBL] [Abstract][Full Text] [Related]
10. Translation of a circulating miRNA signature of melanoma into a solid tissue assay to improve diagnostic accuracy and precision.
Laar RV; King S; McCoy R; Saad M; Fereday S; Winship I; Uzzell C; Landgren A
Biomark Med; 2021 Sep; 15(13):1111-1122. PubMed ID: 34184547
[No Abstract] [Full Text] [Related]
11. A plasma microRNA panel for early detection of colorectal cancer.
Wang S; Xiang J; Li Z; Lu S; Hu J; Gao X; Yu L; Wang L; Wang J; Wu Y; Chen Z; Zhu H
Int J Cancer; 2015 Jan; 136(1):152-61. PubMed ID: 23456911
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
[TBL] [Abstract][Full Text] [Related]
13. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
14. m
Zhang B; Chen Z; Tao B; Yi C; Lin Z; Li Y; Shao W; Lin J; Chen J
Mol Cancer; 2021 Dec; 20(1):170. PubMed ID: 34930277
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the Diagnostic Efficiency of a Liquid Biopsy Assay for Early Detection of Gastric Cancer.
Izumi D; Zhu Z; Chen Y; Toden S; Huo X; Kanda M; Ishimoto T; Gu D; Tan M; Kodera Y; Baba H; Li W; Chen J; Wang X; Goel A
JAMA Netw Open; 2021 Aug; 4(8):e2121129. PubMed ID: 34427680
[TBL] [Abstract][Full Text] [Related]
16. A 5-microRNA signature identified from serum microRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer.
Zhang Y; Roth JA; Yu H; Ye Y; Xie K; Zhao H; Chang DW; Huang M; Li H; Qu J; Wu X
Carcinogenesis; 2019 Jul; 40(5):643-650. PubMed ID: 30428030
[TBL] [Abstract][Full Text] [Related]
17. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of circulating MiR-30b-5p identifies advanced breast cancer.
Estevão-Pereira H; Lobo J; Salta S; Amorim M; Lopes P; Cantante M; Reis B; Antunes L; Castro F; Palma de Sousa S; Gonçalves CS; Costa BM; Henrique R; Jerónimo C
J Transl Med; 2019 Dec; 17(1):435. PubMed ID: 31888645
[TBL] [Abstract][Full Text] [Related]
19. A liquid biopsy signature for predicting early recurrence in patients with gastric cancer.
Okuno K; Watanabe S; Roy S; Kanda M; Tokunaga M; Kodera Y; Kinugasa Y; Goel A
Br J Cancer; 2023 Apr; 128(6):1105-1116. PubMed ID: 36631634
[TBL] [Abstract][Full Text] [Related]
20. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
